Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)

Clinical trial NCT03141671 · UNKNOWN

Trial details

NCT number: NCT03141671
Sponsor: Dana-Farber Cancer Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2017-11-24
Primary completion: 2025-04-05
Enrollment: 345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.